DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Clinical trial NCT06388421 · RECRUITING

Trial details

NCT number: NCT06388421
Sponsor: United Therapeutics
Status: RECRUITING
Study type: OBSERVATIONAL

Pulmonary Hypertension Due to Lung Diseases and Hypoxia Pulmonary Hypertension Interstitial Lung Disease

Start date: 2025-01-23
Primary completion: 2030-09-01
Enrollment: 900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.